Bictegravir/emtricitabine/tenofovir alafenamide, sold under the brand name Biktarvy, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. From Wikipedia
HIV and liver disease drug sales bolstered earnings, while oncology, COVID antiviral, and cell therapy segments underperformed, prompting reaffirmation of full-year guidance.
